Stockreport

Regeneron (REGN) Valuation Check After Japan Clears Dupixent for Pediatric Severe Asthma Expansion [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF See our latest analysis for Regeneron Pharmaceuticals. The Dupixent news lands while Regeneron's momentum is clearly building, with a 90 day share price return of abo [Read more]